Design of biodegradable, implantable devices towards clinical translation
Biodegradable materials, including natural and synthetic polymers and hydrolyzable metals,
constitute the main components of temporary, implantable medical devices. Besides the …
constitute the main components of temporary, implantable medical devices. Besides the …
[HTML][HTML] Advances in coatings on magnesium alloys for cardiovascular stents–a review
ZQ Zhang, YX Yang, JA Li, RC Zeng, SK Guan - Bioactive materials, 2021 - Elsevier
Magnesium (Mg) and its alloys, as potential biodegradable materials, have drawn wide
attention in the cardiovascular stent field because of their appropriate mechanical properties …
attention in the cardiovascular stent field because of their appropriate mechanical properties …
Bioresorbable scaffolds versus metallic stents in routine PCI
JJ Wykrzykowska, RP Kraak, SH Hofma… - … England Journal of …, 2017 - Mass Medical Soc
Background Bioresorbable vascular scaffolds were developed to overcome the
shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We …
shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We …
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions …
PW Serruys, B Chevalier, D Dudek, A Cequier… - The Lancet, 2015 - thelancet.com
Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for
treatment for coronary artery disease, no data from comparisons with its metallic stent …
treatment for coronary artery disease, no data from comparisons with its metallic stent …
Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors
S Puricel, F Cuculi, M Weissner, A Schmermund… - Journal of the American …, 2016 - jacc.org
Background Recent reports suggest an elevated incidence of bioresorbable vascular
scaffold (BVS) thrombosis (scaffold thrombosis [ScT]). Objectives This study investigated …
scaffold (BVS) thrombosis (scaffold thrombosis [ScT]). Objectives This study investigated …
Fully bioresorbable vascular scaffolds: lessons learned and future directions
H Jinnouchi, S Torii, A Sakamoto… - Nature Reviews …, 2019 - nature.com
Fully bioresorbable scaffolds (BRS) were designed to overcome the limitations of metallic
drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal …
drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal …
Cardiovascular stents: overview, evolution, and next generation
S Borhani, S Hassanajili, SH Ahmadi Tafti… - Progress in …, 2018 - Springer
Compared to bare-metal stents (BMSs), drug-eluting stents (DESs) have been regarded as a
revolutionary change in coronary artery diseases (CADs). Releasing pharmaceutical agents …
revolutionary change in coronary artery diseases (CADs). Releasing pharmaceutical agents …
Everolimus-eluting bioresorbable scaffolds for coronary artery disease
SG Ellis, DJ Kereiakes, DC Metzger… - … England Journal of …, 2015 - Mass Medical Soc
Background In patients with coronary artery disease who receive metallic drug-eluting
coronary stents, adverse events such as late target-lesion failure may be related in part to …
coronary stents, adverse events such as late target-lesion failure may be related in part to …
1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis
Background Compared with metallic drug-eluting stents, bioresorbable vascular scaffolds
(BVS) offer the potential to improve long-term outcomes of percutaneous coronary …
(BVS) offer the potential to improve long-term outcomes of percutaneous coronary …
Bioresorbable scaffolds: rationale, current status, challenges, and future
Current generation of drug-eluting stents has significantly improved the outcomes of
percutaneous coronary intervention by substantially reducing in-stent restenosis and stent …
percutaneous coronary intervention by substantially reducing in-stent restenosis and stent …